Search Results 1001-1010 of 13332 for monoclonal antibody
History of clinically significant hypersensitivity associated with monoclonal antibody therapies or components of the emicizumab injection. Eligibility last ...
The concern, the thing that keeps me up at night about this is that it will evade the monoclonal antibodies that we have to either prevent or treat SARS CoV-2.
Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients. Transpl Infect Dis. 2022 Feb; 24 (1):e13759 Epub 2021 Dec 07. View PubMed ...
Antibody-drug conjugates, such as lorvotuzumab mertansine, are created by ... monoclonal antibody; ≥ 2 weeks must have elapsed since local palliative ...
Vaccination should be delayed by 90 days for their children who received monoclonal antibody or convalescent plasma or were given the diagnosis of COVID-19 — ...
History of severe allergic or anaphylactic reactions to monoclonal antibody therapy (or recombinant antibody-related fusion proteins). Patients with known ...
Monoclonal antibodies, such as durvalumab and tremelimumab, may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high ...
The purpose of this study is to evaluate the utility of using anti-HLA antibody titer to measure the effectiveness of antibody lowering therapy (i.e. ...
Monoclonal antibodies: Update on this COVID-19 experimental therapy. Related Articles. Brain-body connection: Expert shares tips to reduce risk of cognitive ...
monoclonal antibodies (MAbs). ... Exclusion Criteria Specific to Cohorts D and E. - Prior use of any monoclonal antibody (e.g., anti-CD20), radioimmunoconjugate, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.